Tuesday, May 26, 2015 7:18:05 AM
http://www.nanoviricides.com/press%20releases/2015/NanoViricides%20Provides%20an%20Update%20on%20Its%20Progress%20over%20the%20Last%20Quarter.html
http://www.nanoviricides.com/press%20releases/2015/NanoViricides%20Discusses%20the%20Strong%20Effectiveness%20of%20Its%20Anti-Herpes%20Drug%20Candidates%20in%20a%20Lethal%20Animal%20Model%20of%20Dermal%20Herpes%20Infection.html
No, I don't know of any connection between the companies and NanoViricides, Inc. however, we all know NanoViricides, Inc. is not in the business designing/manufacturing lab instruments/equipment. Whatever technology/instruments/equipment NanoViricides, Inc. is employing to scale up it must be guaranteed to scale up. If it is not Microfluidics Corp. then it is about other competing technology/equipment/instruments employed for scale up synthesis of their therapeutic drugs.
For example, from Microfluidics Corp.
http://www.microfluidicscorp.com/
Rob Lee, VP of Particle Sciences makes reference to particle size characterization and/or formula characterization. NanoViricides, Inc. has made reference in PR about a Large Scale Characterization Group at the new Shelton pilot plant. They work with companies like MicroFluidics Corp. on how to improve their equipment or increase capabilities of their equipment.
From another website:
Q: What are the characterization methods of nanoparticles synthesized...how do we know that the nanoparticles have been synthesized?
Is it a chemical, physical or biological method?
...
A: João Conde · Massachusetts Institute of Technology
Atomic Force Microscopy (AFM), Scanning Electron Microscopy (SEM), Transmission Electron Microscopy (TEM), Light-Scattering microscopy, FT-IR, Zeta potential, Dynamic Light Scattering (DLS), Fluorescence, UV-VIS molecular absorption, etc....
NanoViricides, Inc. is not alone in their objective to scale up cGLP and cGMP.
http://www.nanoviricides.com/press%20releases/2015/NanoViricides%20Files%20Quarterly%20Report%20for%20Period%20Ending%202015-03-31.html
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM